Edgewise Therapeutics, Inc. (EWTX)
27.40
+0.80
(+3.03%)
USD |
NASDAQ |
Jan 16, 16:00
27.40
0.00 (0.00%)
After-Hours: 16:52
Edgewise Therapeutics Total Liabilities (Quarterly): 24.82M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 412.37M |
| Omeros Corp. | 406.18M |
| Gilead Sciences, Inc. | 37.08B |
| Agios Pharmaceuticals, Inc. | 101.38M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 583.47M |
| Shareholders Equity (Quarterly) | 558.65M |
| Debt to Equity Ratio | 0.0075 |
| Current Ratio | 26.51 |
| Net Debt Paydown Yield | 0.01% |